2013
NIH Effort Gambles on Mysterious Extracellular RNAs
Abstract: A $17 million research program, announced this month by the U.S. National Institutes of Health, aims to determine whether RNA molecules are deliberately released by cells as hormonelike signals—and whether such extracellular RNAs can be harnessed for diagnosis and treatment of human diseases.
Search citation statements
Paper Sections
Select...
11
2
1
0
Citation Types
1
8
0
0
Year Published
Range
2014
2021
Publication Types
Select...
14
Relationship
0
14
Authors
Journals
Cited by 14 publications
(9 citation statements)
References 0 publications
1
8
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…However, HSV-1 is
well-known for its extensive ability to suppress immunity in cells that it infects
(Melchjorsen et al, 2009), so
SIDT2-mediated bystander activation – whereby uninfected host cells take up,
detect, and respond to extracellular HSV-1 dsRNA released from infected cells
– may represent an important counter strategy for host immunity. Along
similar lines, recent in vitro experiments have demonstrated a role
for dsRNA-based activation of bystander cells in limiting hepatitis C virus (HCV)
infection (Dansako et al, 2013), but our
results provide evidence that this activation is important in vivo
and highlight a physiological role for extracellular RNA at a time when this is a
matter of considerable interest and debate (Leslie,
2013). …”
Section: Discussion
supporting
confidence: 71%
Abstract